Physician Survey: Benchmarking brand health in the US psoriasis market

The psoriasis market represents one of Big Pharma's key battlegrounds and is poised to become increasingly more competitive over the next few years.

We recently surveyed 100 experienced US dermatologists to identify which marketed psoriasis brands they are most and least likely to recommend to their colleagues and to which psoriasis brands they are most loyal.

FirstWord Pharma PLUS subscribers will be able to read our analysis of the key findings from this survey on Tuesday. To register your interest in becoming a FirstWord Pharma PLUS subscriber, contact us at

Gain a competitive edge - informed pharma professionals rely on FirstWord

FirstWord is an innovative industry intelligence leader serving over 260,000 pharma professionals globally. FirstWord Pharma PLUS is designed to help you gain a competitive edge by making key decisions with speed and confidence through the delivery of up-to-the-minute personalised and comprehensive news, insight, analysis, physician and key opinion leader views of importance to your products and company.

To read more Physician Views articles, click here.